Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally

 

CDCs global health priorities include efforts towards ending the global tuberculosis (TB) epidemic by: expanding access to improved screening, contact tracing, and diagnostic tools to find the missing TB cases (FIND); optimizing treatment for TB and multi-drug-resistant (MDR) TB, including identifying and evaluating better treatment regimens, and expanding access to care and treatment (CURE); breaking the cycle of TB transmission by strengthening infection control, identifying TB hotspots to target screening, and scaling-up treatment to prevent TB (PREVENT); and helping countries strengthen their surveillance and laboratory systems, and workforce and research capacity to support sustainable health systems including promoting the wider use and adoption of recommended TB strategies and guidelines (SUSTAIN).

Active 93.494 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Public Law The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003; The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008-Public Law 108-25; Public Law 110-293, Title 42 [42 USC] U.S.C. Section 307 [42 USC 242l], as amended and Section 301(a) [42 USC 241(a)], as amended
Section 307 of the Public Health Service Act [42 USC 242/], as amended; Section 301(a) of the Public Health Service Act [42 USC 241(a)], as amended; Public Law 108-25, the United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003; Public Law 110-293, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 Competition is open, limited, or single eligibility by authorizing legislation. This is only for non-research and research activities supported by CDC/ATSDR. For the definition of research, please see the CDC website at the following Internet address: http://www.cdc.gov/od/science/quality/resources Requirements for application are stated in each Notice of Funding Opportunity (NOFO). Preapplication coordination is not applicable. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any. Contact the headquarters or regional location, as appropriate for application deadlines From 60 to 90 days. Not applicable. From 60 to 90 days. Cooperative agreement period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government. Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC. Uses and Restrictions are specified in individual Notice of Funding Opportunities. Funds may be spent for reasonable program purposes, including personnel, travel, operating costs including supplies, fuel for transportation, utilities, staff training costs including registration fees and purchase and rental of training related equipment, and purchase of reagents, test kits and laboratory equipment for Tuberculosis (TB) testing and services. Equipment may be purchased if deemed necessary to accomplish program objectives; however, prior approval by CDC officials must be requested in writing. All requests for funds contained in the budget shall be stated in U.S. dollars. Once an award is made, CDC will not compensate foreign grantees for currency exchange fluctuations through the issuance of supplemental awards. The costs that are generally allowable in grants to domestic organizations are allowable to foreign institutions and international organizations, with the following exception: With the exception of the American University, Beirut, and the World Health Organization (WHO), Indirect Costs will not be paid (either directly or through sub-award) to organizations located outside the territorial limits of the United States or to international organizations regardless of their location. The applicant may contract with other organizations under this program; however, the applicant must perform a substantial portion of the activities (including program management and operations, and delivery of prevention services for which funds are required). You must obtain an annual audit of these CDC funds (program-specific audit) by a U.S.-based audit firm with international branches and current licensure/authority in-country, and in accordance with International Accounting Standards or equivalent standard(s) approved in writing by CDC. A fiscal Recipient Capability Assessment may be required, prior to or post award, in order to review the applicant's business management and fiscal capabilities regarding the handling of U.S. Federal funds. Please see the specific Notice of Funding Opportunity (NOFO). Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. Not applicable. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award None/Not specified. Carla (Casey) Boudreau
1600 Clifton Rd. NE
Mail stop H21-9
Atlanta, GA 30333 USA
znc5@cdc.gov
Phone: 404-639-8404
Fax: N/A https://www.cdc.gov 75-0955-0-1-551 (Cooperative Agreements) FY 22$750,000.00; FY 23 est $1,724,866.00; FY 24 est $3,999,999.00; FY 21$1,000,000.00; FY 20$3,069,815.00; FY 19$2,459,500.00; FY 18 - Awards may range from $700,000 to $3,500,000. Average award is expected at $2,491,622. Recipients must comply with the administrative and public policy requirements outlined in 45 CFR Part 75 and the HHS Grants Policy Statement, as appropriate. The HHS Grants Policy Statement is available at http://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf. The full text of the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards, 45 CFR 75, can be found at: https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-75 Not applicable.